title: Physical Characterization of Gemini Surfactant-Based Synthetic Vectors for the Delivery of Linear Covalently Closed (LCC) DNA Ministrings.
abstract: In combination with novel linear covalently closed (LCC) DNA minivectors, referred to as DNA ministrings, a gemini surfactant-based synthetic vector for gene delivery has been shown to exhibit enhanced delivery and bioavailability while offering a heightened safety profile. Due to topological differences from conventional circular covalently closed (CCC) plasmid DNA vectors, the linear topology of LCC DNA ministrings may present differences with regards to DNA interaction and the physicochemical properties influencing DNA-surfactant interactions in the formulation of lipoplexed particles. In this study, N,N-bis(dimethylhexadecyl)-α,ω-propanediammonium(16-3-16)gemini-based synthetic vectors, incorporating either CCC plasmid or LCC DNA ministrings, were characterized and compared with respect to particle size, zeta potential, DNA encapsulation, DNase sensitivity, and in vitro transgene delivery efficacy. Through comparative analysis, differences between CCC plasmid DNA and LCC DNA ministrings led to variations in the physical properties of the resulting lipoplexes after complexation with 16-3-16 gemini surfactants. Despite the size disparities between the plasmid DNA vectors (CCC) and DNA ministrings (LCC), differences in DNA topology resulted in the generation of lipoplexes of comparable particle sizes. The capacity for ministring (LCC) derived lipoplexes to undergo complete counterion release during lipoplex formation contributed to improved DNA encapsulation, protection from DNase degradation, and in vitro transgene delivery.
authors.affiliation: School of Pharmacy, University of Waterloo, 10 Victoria Street S., Kitchener, Ontario, Canada.
authors.forename: Chi Hong
authors.initials: CH
authors.lastname: Sum
authors.affiliation: School of Pharmacy, University of Waterloo, 10 Victoria Street S., Kitchener, Ontario, Canada.|Waterloo Institute for Nanotechnology, University of Waterloo, 200 University Ave W., Waterloo, Ontario, Canada.
authors.forename: Nafiseh
authors.initials: N
authors.lastname: Nafissi
authors.affiliation: School of Pharmacy, University of Waterloo, 10 Victoria Street S., Kitchener, Ontario, Canada.|Waterloo Institute for Nanotechnology, University of Waterloo, 200 University Ave W., Waterloo, Ontario, Canada.
authors.forename: Roderick A
authors.initials: RA
authors.lastname: Slavcev
authors.affiliation: School of Pharmacy, University of Waterloo, 10 Victoria Street S., Kitchener, Ontario, Canada.|Waterloo Institute for Nanotechnology, University of Waterloo, 200 University Ave W., Waterloo, Ontario, Canada.
authors.forename: Shawn
authors.initials: S
authors.lastname: Wettig
mesh_terms: D045744:Cell Line, Tumor; D004270:DNA, Circular / Q000008:administration & dosage* / Q000235:genetics; D004926:Escherichia coli / Q000235:genetics; D005822:Genetic Vectors / Q000008:administration & dosage* / Q000235:genetics; D006801:Humans; D010957:Plasmids / Q000008:administration & dosage* / Q000235:genetics; D013501:Surface-Active Agents / Q000737:chemistry*; D014162:Transfection; D019076:Transgenes
chemical_list: D004270:DNA, Circular; D013501:Surface-Active Agents